We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
81 hedge funds and large institutions have $177M invested in scPharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
540% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $160K
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
13% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 24
11% more funds holding
Funds holding: 73 → 81 (+8)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4.9% less ownership
Funds ownership: 83.47% → 78.57% (-4.9%)
17% less capital invested
Capital invested by funds: $213M → $177M (-$36.5M)
Holders
81
Holders Change
+8
Holders Change %
+10.96%
% of All Funds
1.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
27
Reduced
24
Closed
8
Calls
$1.02M
Puts
$160K
Net Calls
+$864K
Net Calls Change
-$405K
Top Buyers
Top Sellers
| 1 |
RI
RTW Investments
New York
|
-$23.5M |
| 2 |
CAC
Cowen and Company
New York
|
-$12.8M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$5.99M |
| 4 |
Morgan Stanley
New York
|
-$4.23M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.73M |
